Benzinga
Benzinga
Benzinga
giovedì, settembre 24

Artelo Biosciences Inc

ARTLNASDAQ
Trade with Public
Trade with Public
$7.31
3.1676.14%
In chiusura: Sep 23, 5:00 PM EST
$5.75
-1.56-21.4%
Post-mercato: 7:59 PM EST
PRO
Perché si muove?:Artelo Biosciences shares are trading higher after the company announced th...
PanoramicaNotiziePrevisioni utiliEventiObiettivi di prezzoDati finanziariSentimentAzionariatoConfrontaRapporto azionario

Artelo Biosciences Analyst Price Targets

Wall Street analyst price targets and consensus rating for Artelo Biosciences (ARTL).

Price Target Range — 7 Quarters

Analyst Consensus — 4 Analysts

2Buy
2Hold
Consensus RatingBuy# Analysts4Avg. Consensus PT$891Upside to Avg. PT+15406.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →
DateFirmAnalystActionRating ChangePrice Target
Nov 19, 2025Maxim GroupJason McCarthyDowngradeBuy→Hold—
Sep 8, 2025D. Boral CapitalJason KolbertDowngradeBuy→Hold—
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Maxim Group Downgrades Artelo Biosciences to Hold

Maxim Group analyst Jason McCarthy downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.
Benzinga Newsdesk

This Science Applications International Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Monday

Avi Kapoor

PRO
D. Boral Capital Downgrades Artelo Biosciences to Hold

D. Boral Capital analyst Jason Kolbert downgrades Artelo Biosciences (NASDAQ:ARTL) from Buy to Hold.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.
Benzinga Newsdesk

PRO
D. Boral Capital Maintains Buy on Artelo Biosciences, Maintains $18 Price Target

D. Boral Capital analyst Jason Kolbert maintains Artelo Biosciences (NASDAQ:ARTL) with a Buy and maintains $18 price target.
Benzinga Newsdesk

Dati e API: API Benzinga · API notizie azionarie · API valutazioni analisti · API logo aziende

Dati di mercato forniti da API Benzinga

Benzinga

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO

© 2026 Benzinga | All Rights Reserved